Internal Medicine, Hematology & Oncology · Fort Wayne, IN
NPI
1710116603
Since 2009
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
2
Medicare group memberships
Hospitals
4
Hospital affiliations
11050 Parkview Circle Dr
Fort Wayne, IN, 46845
Phone (833) 724-8326
Groups this clinician bills Medicare through
Medicare paid, 2023
$9,762
560 services
Medicare patients, 2023
18
Average age 69
Drug cost, 2024
$6.3M
1,471 prescriptions
Company payments
-
None reported
Medicare prescription drug claims, 2024
In 2024, the drug Jennifer P Brow prescribed most often to Medicare patients was Hydroxyurea, with 190 prescriptions and refills. In total Jennifer P Brow wrote 1,471 Medicare prescriptions that cost $6.3M.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-02-02.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Hydroxyurea Generic | 190 | 466 | 52 | $7,423 |
| Acyclovir Generic | 125 | 256 | 35 | $2,813 |
| Dexamethasone Generic | 117 | 130 | 31 | $1,365 |
| Brukinsa Zanubrutinib | 117 | 117 | 13 | $1.5M |
| Lenalidomide Generic | 80 | 80 | 11 | $915K |
| Ondansetron Hcl Generic | 60 | 60 | 22 | $458 |
| Prochlorperazine Maleate Generic | 42 | 42 | 23 | $513 |
| Pomalyst Pomalidomide | 39 | 39 | Under 11 | $942K |
| Oxycodone Hcl Generic | 37 | 37 | 31 | $343 |
| Lorazepam Generic | 37 | 37 | 28 | $194 |
| Bosulif Bosutinib | 36 | 36 | Under 11 | $581K |
| Prednisone Generic | 33 | 44 | 15 | $260 |
| Jakafi Ruxolitinib Phosphate | 30 | 30 | Under 11 | $324K |
| Venclexta Venetoclax | 29 | 29 | Under 11 | $523K |
| Nivestym Filgrastim-Aafi | 24 | 24 | Under 11 | $24K |
Brand drugs: 428 claims; generic drugs: 1,043 claims; opioid claims: 45.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Jennifer P Brow were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.